Sepideh Yazdianpour is an MSc candidate in Pharmaceutical Analysis, Technology and Biopharmaceuticals at King's College London. Her current research, conducted in collaboration with M2M Pharmaceuticals, focuses on the development and physicochemical characterisation of spray-dried inhalable biologic formulations for pulmonary drug delivery.
Prior to joining King's College London, Sepideh worked in the biopharmaceutical industry as a Clinical Development Lead and Clinical Development and Regulatory Affairs Advisor, contributing to the clinical development and regulatory strategy of biosimilar monoclonal antibodies and other biologic products. She holds an MSc in Microbial Biotechnology and a BSc in Microbiology.
Her research interests include inhaled biologics, pulmonary drug delivery, formulation development, pharmaceutical particle engineering, and the clinical and regulatory development of biological medicines.
Sepideh has authored a peer-reviewed scientific publication in microbiology and has presented her work at international scientific meetings. Through her combined academic and industry experience, she aims to contribute to the translation of innovative biologic formulations from research into clinical application.